TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 4,060.00
+125.00 (3.18%)
At close: Oct 16, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 121.96 billion as of October 16, 2026. It is the 26,186th most valuable company in the world and the 1,154th biggest in South Korea. Its market cap has decreased by 25.13% in one year.
Market Cap
121.96B
Enterprise Value
129.05B
Revenue
15.00B
Global Rank
Country Rank
#1,154 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 22, 2019, TiumBio's market cap has decreased from 311.90B to 121.96B, a decrease of -60.90%. That is a compound annual growth rate of -12.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 121.96B | -28.51% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 164.26B |
| ISU Abxis | 159.43B |
| Bio Solution | 157.92B |
| Ensol Biosciences | 140.17B |
| Kanaph Therapeutics | 133.27B |
| ViGenCell | 111.11B |
| Y-Biologics | 107.57B |
| AriBioLab | 103.37B |